Not an SEC registrant

Mapp Biopharmaceutical, INC.

Customers

1 federal agency

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$83.1M

FY2026 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 1

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $83.1M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	$83.1M	FY 2026	8	$61.3M → $3.1M → $47.9M → $83.1M	75A50122C00076
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION. Award 75A50122C00076 on USAspending.gov ↗ Largest of 8 awards in FY2026: $44.3M obligated

Alerts are coming

Get an email when Mapp Biopharmaceutical, INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.